Dr. Laurie Snyder
Dr. Laurie Snyder is an Associate Professor of Medicine in the division of Pulmonary and Critical Care at Duke University and a member of the Duke Clinical Research Institute. Her clinical and research interests are in advanced lung disease, immunology and lung transplantation.
What can a patient registry tell us about the course of idiopathic pulmonary fibrosis?
Research published today in Respiratory Research presents findings from the IPF-PRO Registry, a nationwide US registry collecting data on the clinical course of Idiopathic pulmonary fibrosis (IPF) and its impact on patients.
Courtesy of Dr. Laurie Snyder
Idiopathic pulmonary fibrosis, or IPF, is a rare, debilitating lung disease that mainly affects individuals over the age of 60. IPF is characterized by progressive fibrosis (scarring) of the lungs, which leads to a loss of lung volume and an impaired ability of the lungs to exchange gases. Ultimately IPF is fatal.
.jpeg)
No hay comentarios:
Publicar un comentario